A phase II study of eribulin in recurrent or refractory osteosarcoma: A report from the Children's Oncology Group.

2018
https://researcherprofiles.org/profile/30700055
30378256
Isakoff MS, Goldsby R, Villaluna D, Krailo MD, Hingorani P, Collier A, Morris CD, Kolb EA, Doski JJ, Womer RB, Gorlick R, Janeway KA